Expression of B-Cell-Associated Antigens During B-Cell Ontogeny

  • B. Dörken
Conference paper
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 131)

Abstract

The development of the B-cell lineage from stem cells to mature B lymphocytes and antibody-secreting plasma cells is a multistep process of differentiation. Stages of B-cell maturation have been characterized by the rearrangement and expression of the immunoglobulin (Ig) genes, by surface markers, and by susceptibilities to growth and differentiation factors (Tonegawa 1983; Alt et al. 1986; Campana et al. 1985; Loken et al. 1987; Kishimoto 1987; Cooper 1987). B-lineage acute lymphoblastic leukemia’s are presumed to result from leukemogenic events that occur in progenitor B cells during early phases of B-cell ontogeny and lead to a maturational arrest at discrete stages of early B-cell differentiation (Greaves 1986). Recently published data on molecular components of the B-cell antigen receptor complex, molecules selectively expressed in pre-B cells, and B-lineage- associated differentiation antigens have provided a new insight into early B-cell development, and this will contribute to a better understanding of the cell biology of B-lineage acute lymphoblastic leukemia’s.

Keywords

Lymphoma Leukemia Recombination Polypeptide Disulfide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alt FW, Blackwell TK, DePinho RA, Reth MG, Yancopoulos GD (1986) Regulation of genome rearrangement events during lymphocyte differentiation. Immunol Rev 89: 5–30PubMedCrossRefGoogle Scholar
  2. Bauer SR, Kudo A, Melchers F (1988) Structure and pre B lymphocyte-restricted expression of the VpreB gene in humans and conservation in other mammalian species. EMBO J 7: 111–116PubMedGoogle Scholar
  3. Bauer SR, Kubagawa H, MacLennan I, Melchers F (1991) VpreB gene expression in hematopoietic malignancies: a lineage- and stage-restricted marker for B-cell precursor leukemias. Blood 78: 1581–1588PubMedGoogle Scholar
  4. Blackwell TK, Alt FW (1989) Molecular characterization of the lymphoid V ( D) J recombination activity. J Biol Chem 264: 10327PubMedGoogle Scholar
  5. Campana D, Janossy G, Bofill M, Trejdosievicz LK, Ma D, Hoffbrand AV, Mason DY, Lebacq AM, Forster HK (1985) Human B cell development: I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. J Immunol 134: 1524–1530PubMedGoogle Scholar
  6. Cherayil BJ, Pillai S (1991) The GO/A5 surrogate immunoglobulin light chain is expressed on the surface of transitional B lymphocytes in murine bone marrow. J Exp Med 173: 111–116PubMedCrossRefGoogle Scholar
  7. Cooper MD (1987) Current concepts, B lymphocytes normal development and function. N Engl J Med 317: 1452PubMedCrossRefGoogle Scholar
  8. Desiderio SV, Yancopoulos GD, Paskind M, Thomas E, Boss MA, Landau H, Alt FW, Baltimore D (1984) Insertions of N regions into heavy chains genes is correlated with expression of terminal deoxycotransferase in B cells. Nature 311: 752–755PubMedCrossRefGoogle Scholar
  9. Dörken B, Moldenhauer G, Pezzutto A, Schwartz R, Feller A, Kiesel S, Nadler LM (1986) HD39 ( B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes. J Immunol 136: 4470–4479PubMedGoogle Scholar
  10. Dörken B, Pezzutto A, Köhler M, Thiel E, Hunstein W (1987) Expression of cytoplasmic CD22 in B-cell ontogeny. In: McMichael AJ (ed) Leukocyte typing III. Oxford University Press, Oxford, pp 474–476Google Scholar
  11. Dörken B, Möller P, Pezzutto A, Schwartz-Albiez RS, Moldenhauer G (1989) B cell antigens: section report, CD10, CD19–24, CD37–40, CD72-w78, CD45-like group, unclustered antibodies. In: Knapp W, Dörken B, Gilks WR, Rieber EP, Schmidt RE, Stein H, von dem Borne AEGK (eds) Leukocyte typing IV. Oxford University Press, OxfordGoogle Scholar
  12. Einfeld DA, Brown JP, Valentine MA, Clark EA, Ledbetter JA (1988) Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains. EMBO J 7: 711–718PubMedGoogle Scholar
  13. Evans RJ, Hollis GF (1991) Genomic structure of the human Ig λ gene suggests that it may be expressed as an Ig λ 14.1-like protein or as a canonical B cell Ig λ light chain: implications for Ig X gene evolution. J Exp Med 173: 305–311PubMedCrossRefGoogle Scholar
  14. Gordon J, Hamblin TJ, Smith JL, Stevenson FK, Stevenson GT (1981) A human B lymphoma synthesizing and expressing surface μ chain in the absence of detectable light chain. Blood 58: 552–556PubMedGoogle Scholar
  15. Greaves MF (1986) Differentiation-linked leukemogenesis in lymphocytes. Science 234: 697–704PubMedCrossRefGoogle Scholar
  16. Gu H, Kitamura D, Rajewsky K (1991) B cell development regulated by gene rearrangement: arrest of maturation by membrane-bound Dμ protein and selection of Dλ element reading frames. Cell 65: 47–54PubMedCrossRefGoogle Scholar
  17. Hendershot L, Levitt D (1984) Analysis of surface of μ chain expression in human lymphoblastoid lines that do not produce light chains. J Immunol 132: 502–509PubMedGoogle Scholar
  18. Hermanson GG, Eisenberg D, Kincade PW, Wall R (1988) B29: a member of the immunoglobulin gene superfamily exclusively expressed on B lineage cells. Proc Natl Acad Sci USA 85: 6890–6894PubMedCrossRefGoogle Scholar
  19. Hollis GF, Evans RJ, Stafford-Hollis JM, Korsmeyer SJ, McKearn JP (1989) Immunoglobulin X light-chain-related genes 14.1 and 16.1 are expressed in pre-B cells and may encode the human immunoglobulin co light-chain protein. Proc Natl Acad Sci USA 86: 5552–5556PubMedCrossRefGoogle Scholar
  20. Hombach J, Tsubata F, Leclercq L, Strappert H, Reth M (1990a) Molecular components of the B cell antigen receptor complex of the IgM class. Nature 343: 760–762PubMedCrossRefGoogle Scholar
  21. Hombach J, Lottspeich F, Reth M (1990b) Identification of the genes encoding the IgM-α and Ig-β components of the IgM antigen receptor complex by amino terminal sequencing. Eur J Immunol 20: 2795–2799PubMedCrossRefGoogle Scholar
  22. Janossy G, Bollum FJ, Bradstock KF, McMichael A, Rapson N, Greaves MF (1979) Terminal transferase-positive human bone marrow cells exhibit the antigenic phenotype of common acute lymphoblastic leukemia. J Immunol 123: 1525–1529PubMedGoogle Scholar
  23. Karasuyama H, Kudo A, Melchers F (1990) The proteins encoded by the VpreB and λ5 pre-B cell-specific genes can associate with each other and with λ heavy chains. J Exp Med 172: 969–972PubMedCrossRefGoogle Scholar
  24. Kashiwamura SI, Koyama T, Matsuo T, Steinmetz M, Sakaguchi N (1990) Structure of the murine mb-1 gene encoding a putative surface IgM-associated molecule. J Immunol 145: 337–343PubMedGoogle Scholar
  25. Kerr WG, Cooper MD, Feng L, Burrows PD, Hendershot LM (1989) Mu heavy chains can associate with a pseudo-light chain complex (ΨL) in human pre-B cell lines. Int Immunol 4: 355–361CrossRefGoogle Scholar
  26. Kishimoto T (1987) B-cell stimulatory factors (BSFs) Molecular structure, biological function, and regulation of expression. J Clin Immunol 7: 343–348PubMedCrossRefGoogle Scholar
  27. Kudo A, Melchers F (1987) A second gene, VpreB in the λ5 locus of the mouse, which appears to be selectively expressed in pre-B lymphocytes. EMBO J 6: 2267–2272PubMedGoogle Scholar
  28. Loken MD, Shah VO, Dattilio KL, Civin CI (1987) Flow cytometric analysis of human bone marrow: II. Normal B lymphocyte development. Blood 70: 1316–1324PubMedGoogle Scholar
  29. Mason DY, Cordell JL, Tse AGD, van Dongen JJM, van Noesel CJM, Micklem K, Pulford KAF, Valenssi F, Comans-Bitter WM, Borst J, Gatter KC (1991) The IgM-associated protein mb-1 as a marker of normal and neoplastic B cells. J Immunol 147: 2474–2482PubMedGoogle Scholar
  30. Matsumoto AK, Kopicky-Burd J, Carter RH, Tuveson DA, Tedder TF, Fearon DT (1991) Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD 19. J Exp Med 173: 55–64PubMedCrossRefGoogle Scholar
  31. Matsuo T, Kimoto M, Sakaguchi N (1991) Direct identification of the putative surface IgM receptor-associated molecule encoded by murine B cell-specific mb-1 gene. J Immunol 146: 1584–1590PubMedGoogle Scholar
  32. Mattei MG, Fumoux F, Roeckel N, Fougereau M, Schiff C (1991) The human pre-B-specific lambda-like cluster is located in the 22q11.2–22q12.3 region, distal to the Ig Cx locus. Genomics 9: 544–546PubMedCrossRefGoogle Scholar
  33. Nadler LM, Korsmeyer SJ, Anderson KC, Boyd AW, Slaughenhoupt B, Park E, Jensen J, Coral F, Mayer RJ, Sallan SE, Ritz J, Schlossman SF (1984) B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest 74: 332–240PubMedCrossRefGoogle Scholar
  34. Nomura J, Matsuo T, Kubota E, Kimoto M, Sakaguchi N (1991) Signal transmission through the B cell specific MB-1 molecule at the pre-B cell stage. Int Immunol 3: 117–126PubMedCrossRefGoogle Scholar
  35. Paige CJ, Kincade PW, Ralph P (1981) Independent control of immunoglobulin heavy and light chain expression in a murine pre-B cell line. Nature 292: 631–633PubMedCrossRefGoogle Scholar
  36. Pieters R, Thompson LF, Broekema GJ, Huismans DR, Peters GJ, Pals ST, Horst E, Hählen K, Veerman AJP (1991) Expression of 5′-Nucleotidase (CD73) related to other differentiation antigens in leukemias of B-cell lineage. Blood 78: 488–492PubMedGoogle Scholar
  37. Pillai S, Baltimore D (1987) Formation of disulfide-linked μCω2 tetramers in pre-B cells by the 18K ω-immunoglobulin light chain. Nature 329: 172 - 174PubMedCrossRefGoogle Scholar
  38. Pillai S, Baltimore D (1988) The omega and iota surrogate immunoglobulin light chains. Curr Top Microbiol Immunol 137: 136–139PubMedGoogle Scholar
  39. Reth M, Alt FW (1984) Novel immunoglobulin heavy chains are produced from DJH gene segment rearrangements in lymphoid cells. Nature 312: 418–423PubMedCrossRefGoogle Scholar
  40. Rolink A, Melchers F (1991) Molecular and cellular origins of B lymphocyte diversity. Cell 66: 1081–1094PubMedCrossRefGoogle Scholar
  41. Rolink A, Kudo A, Karasuyama H, Kikuchi Y, Melchers F (1991) Long-term proliferating early pre-B cell lines and clones with the potential to develop to surface Ig-positive, mitogen-reactive B cells in vitro and in vivo. EMBO J 10: 327–336PubMedGoogle Scholar
  42. Ryan D, Kossover S, Mitchell S, Frantz C, Hennessy L, Cohen H (1986) Subpopulation of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens. Blood 68: 417–425PubMedGoogle Scholar
  43. Sakaguchi N, Melchers F (1986) λ5, a new light-chain related locus selectively expressed in pre-B lymphocytes. Nature 324: 579–582PubMedCrossRefGoogle Scholar
  44. Sakaguchi N, Kashiwamura SI, Kimoto M, Thalmann P, Melchers F (1988) B lymphocyte-restricted expression of mb-1, a gene with CD33-like structural properties. EMBO J 7: 3457–3464PubMedGoogle Scholar
  45. Schiff C, Bensmana M, Guglielmi P, Millili M, Lefranc MP, Fougereau M (1990) The immunoglobulin λ-like gene cluster (14.1, 16.1 and FX1) contains gene(s) selectively expressed in pre-B cells and is the human counterpart of the mouse λ5 gene. Int Immunol 2: 201–208PubMedCrossRefGoogle Scholar
  46. Schiff C, Milili M, Bossy D, Tabilio A, Falzetti F, Gabert J, Mannono P, Fougereau M (1991) Lambda-like and V preB genes expression: an early B-lineage marker of human leukemias. Blood 78: 1516–1525PubMedGoogle Scholar
  47. Shipp MA, Richardson NE, Sayre PH, Brown NR, Masteller EL, Clayton LK, Ritz J, Reinherz EL (1988) Molecular cloning of the common acute lymphoblastic leukemia antigen ( CALLA) identifies a type II integral membrane protein. Proc Natl Acad Sci USA: 85: 4819–4823PubMedCrossRefGoogle Scholar
  48. Stamenkovic I, Seed B (1988a) Analysis of two cDNA clones encoding the B lymphocyte antigen CD20 (Bl, Bp35), a type III integral membrane protein. J Exp Med 167: 1975–1981CrossRefGoogle Scholar
  49. Stamenkovic I, Seed B (1988b) CD19, the earliest differentiation antigen of the B cell lineage, bears three extracellular immunoglobulin-like domains and an Epstein-Barr virus-related cytoplasmic tail. J Exp Med 168: 1205–1210CrossRefGoogle Scholar
  50. Stamenkovic I, Seed B (1990) The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion. Nature 345: 74–77PubMedCrossRefGoogle Scholar
  51. Stamenkovic I, Sgroi D, Aruffo A, Sy MS, Anderson T (1991) The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and a 2–6 sialytransferase, CD75, on B cells. Cell 66: 1133–1144PubMedCrossRefGoogle Scholar
  52. Tedder TF, Isaacs CM (1989) Isolation of cDNAs encoding the CD19 antigen for human and mouse B lymphocytes. A new member of the immunolgobulin superfamily. J Immunol 143: 712–717PubMedGoogle Scholar
  53. Tedder TF, Klejman G, Schlossman SF, Saito H (1989) Structure of the gene encoding the human B lymphocyte differentiation antigen CD20 ( B1 ). J Immunol 142: 2560–3568PubMedGoogle Scholar
  54. Thompson LF, Ruedi JM, Glass A, Moldenhauer G, Moller P, Low MG, Klemens MR, Massaia M, Lucas AH (1990) Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5′-nucleotidase (CD73). Tissue Antigens 35: 9–19CrossRefGoogle Scholar
  55. Tonegawa S (1983) Somatic generation of antibody diversity. Nature 320: 575–581CrossRefGoogle Scholar
  56. Tsubata T, Reth M (1990) The products of pre-B cell-specific genes (λ,5 and VpreB) and the immunoglobulin μ chain form a complex that is transported onto the cell surface. J Exp Med 172: 973–976PubMedCrossRefGoogle Scholar
  57. Tsubata T, Tsubata R, Reth M (1991) Cell surface expression of the short immunoglobulin μ chain (Dυ protein) in murine pre-B cells is differently regulated from that of the intact u chain. Eur J Immunol (in press)Google Scholar
  58. Uckun FM (1990) Regulation of human B-cell ontogeny. Blood 76:1908–1923PubMedGoogle Scholar
  59. van de Velde H, von Hoegen I, Luo W, Parnes JR, Thielemans K (1991) The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 351: 662–665PubMedCrossRefGoogle Scholar
  60. van Noessel CJM, van Borst J, de Vries EFR, van Lier RAW (1990) Identification of two distinct phosphoproteins as components of the human B cell antigen receptor complex. Eur J Immunol 20: 2789–2793CrossRefGoogle Scholar
  61. Vogler LB, Crist WM, Bockman DE, Pearl ER, Lawton AR, Cooper MD (1978) Pre-B leukemia: a new phenotype of childhood lymphoblast leukemia. N Engl J Med 298: 872–878PubMedCrossRefGoogle Scholar
  62. von Hoegen I, Nakayama E, Parnes JR (1990) Identification of a human protein homologous to the mouse Lyb-2 B cell differentiation antigen and sequence of the corresponding cDNA. J Immunol 144: 4870–4877Google Scholar
  63. Wilson GL, Fox CH, Fauci AS, Kehrl JH (1991) cDNA cloning of the B cell membrane protein CD22: A mediator of B-B cell interactions. J Exp Med 173: 137–146PubMedCrossRefGoogle Scholar
  64. Yamanishi Y, Kakiuchi T, Mizugichi J, Yamamoto T, Tyoshima K (1991) Association of B cell antigen receptor with protein tyrosine kinase lyn. Science 251: 192–194CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1993

Authors and Affiliations

  • B. Dörken
    • 1
  1. 1.Dep. of Medical Oncology and Tumor Immunology, URKVFree University of BerlinBerlinFed. Rep. of Germany

Personalised recommendations